Pharmacogénétique des analogues nucléosidiques : Cytidine déaminase et issue clinique
La prise en charge du cancer reste dépendante de l’utilisation des agents cytotoxiques, avec les analogues nucléosidiques. Au-delà de leur similarité structurelle, certains de ces composés partagent une voie métabolique commune, où la cytidine déaminase apparaît comme enzyme majeure. L’existence d’u...
Main Author: | Serdjebi, Cindy |
---|---|
Other Authors: | Aix-Marseille |
Language: | fr |
Published: |
2015
|
Subjects: | |
Online Access: | http://www.theses.fr/2015AIXM5502/document |
Similar Items
-
Characteristics and efficacy of cytosine and cytidine deaminase
by: Qusay Chalabi, et al.
Published: (2007-01-01) -
Synthesis of a bifunctional cytidine derivative and its conjugation to RNA for in vitro selection of a cytidine deaminase ribozyme
by: Nico Rublack, et al.
Published: (2014-08-01) -
Clinical study of cytidine deaminase in serum of cancer thalassemia and diabetes patients
by: Zahra Hammoudat
Published: (2010-06-01) -
Acquisition of Genetic Aberrations by Activation-Induced Cytidine Deaminase (AID) during Inflammation-Associated Carcinogenesis
by: Tsutomu Chiba, et al.
Published: (2011-06-01) -
Mouse APOBEC1 cytidine deaminase can induce somatic mutations in chromosomal DNA
by: Vincent Caval, et al.
Published: (2019-11-01)